Viral Vector Vaccine Platforms for Rapid Response to Future Pandemics
Director: Peter Pelka | Co-Director: Maya Shmulevitz |
CBRF: $18.9M | BRIF: $38.1M |
This proposal is the largest federal research investment ever received by the University of Manitoba. It is led by Dr. Peter Pelka at the University of Manitoba and Dr. Maya Shmulevitz at the 91ÒùĸÊÓÆµ, with team members also at the University of Calgary and University of Saskatchewan/VIDO. This team brings expertise in virology, immunology, infectious disease, biomedical engineering, health economics, artificial intelligence, and bioprocessing.
Their CBRF program will develop:
- Plug-and-play virus-vectored and protein vaccine platforms. These methods use live viruses and proteins as vaccines and can easily be adapted to any viral pathogen of concern.
- A one-of-a-kind pipeline for characterizing newly developed vaccines.
- A pipeline for vaccine biomanufacturing.
Their BRIF Infrastructure funding will create:
- The PRAIRIE Biologics Accelerator (University of Manitoba)
- A new state-of-the-art 21,000 sq ft biomanufacturing facility, a dedicated space for production of viral vaccines, bioprocess technologies, and training.
- The PRAIRIE One Health Emerging Respiratory Disease (POHERD) Centre and containment Level 3 Ag Laboratory (University of Manitoba)
- For pre-clinical vaccine testing in animal models against high-risk group pathogens.
- The PRAIRIE Immune and Vaccine Optimization and Testing (PIVOT) Core (91ÒùĸÊÓÆµ)
- For developing and characterizing new vaccine platforms with several members from the Department of Medical Microbiology and Immunology making contributions.
Team Members
Peter Pelka, University of Manitoba
Vanessa Meier-Stephenson, 91ÒùĸÊÓÆµ
Ryan Noyce, 91ÒùĸÊÓÆµ
Sue Tsai, 91ÒùĸÊÓÆµ
D. Lorne Tyrrell, 91ÒùĸÊÓÆµ
Matthew Macauley, 91ÒùĸÊÓÆµ
Brian Mark, University of Manitoba
Elham Salimi, University of Manitoba
Hector De la Hoz Siegler, University of Calgary
Guido van Marle, University of Calgary
Canadian Food Inspection Agency
Defence 91ÒùĸÊÓÆµ and Development Canada
National 91ÒùĸÊÓÆµ Council of Canada
Public Health Agency of Canada
DMKS Consulting
Lumenix
STEMCELL Technologies Inc.
Maya Shmulevitz, 91ÒùĸÊÓÆµ
Troy Baldwin, 91ÒùĸÊÓÆµ
Xavier Clemente-Casares, 91ÒùĸÊÓÆµ
Hosna Jabbari, 91ÒùĸÊÓÆµ
Kevin Kane, 91ÒùĸÊÓÆµ
Keith Fowke, University of Manitoba
Barbara Porto, University of Manitoba
Jörg Stetefeld, University of Manitoba
Craig Jenne, University of Calgary
Suresh Tikoo, University of Saskatchewan
91ÒùĸÊÓÆµ Cell Therapy Manufacturing
BioHubNet
Ottawa Health 91ÒùĸÊÓÆµ Institute
Institute for Health Economics
VIDO
Emergent BioSolutions Inc.
Medicure Inc.